AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,892,610 | +73.0% | 213,000 | +113.0% | 0.99% | +79.6% |
| Q3 2022 | $2,828,000 | +206.4% | 100,000 | +400.0% | 0.55% | +107.2% |
| Q3 2021 | $923,000 | -44.2% | 20,000 | -33.3% | 0.26% | -41.8% |
| Q2 2021 | $1,653,000 | -25.6% | 30,000 | -30.2% | 0.46% | -28.3% |
| Q1 2021 | $2,221,000 | -31.7% | 43,000 | -42.7% | 0.64% | -34.3% |
| Q4 2020 | $3,250,000 | -22.6% | 75,000 | -37.5% | 0.97% | -24.7% |
| Q3 2020 | $4,200,000 | -47.6% | 120,000 | -20.0% | 1.28% | -46.5% |
| Q2 2020 | $8,022,000 | +50.7% | 150,000 | 0.0% | 2.40% | +2.5% |
| Q1 2020 | $5,322,000 | -41.3% | 150,000 | -21.1% | 2.34% | -33.7% |
| Q4 2019 | $9,073,000 | – | 190,000 | – | 3.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |